Entera Bio Ltd. Cash And Cash Equivalents At Carrying Value

• Entera Bio Ltd. showed a decrease of -17.9% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
• This data is from Entera Bio Ltd.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
• XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 6 years of available data (2020 to 2025), Entera Bio Ltd.'s Cash And Cash Equivalents At Carrying Value has declined by 17.3%.
• Historical annual values: Fiscal year 2025: $7.11 million | Fiscal year 2024: $8.66 million | Fiscal year 2023: $11.02 million | Fiscal year 2022: $12.31 million | Fiscal year 2021: $24.89 million | Fiscal year 2020: $8.59 million.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026